2022
Why Increased Diversity in Dermatologic Clinical Trials Is Not Inherently Ethical—An Evidence-Based, Community-Engaged Approach to Diverse Trial Recruitment
Asabor EN, Cohen JM, Aysola J. Why Increased Diversity in Dermatologic Clinical Trials Is Not Inherently Ethical—An Evidence-Based, Community-Engaged Approach to Diverse Trial Recruitment. JAMA Dermatology 2022, 158: 1219-1219. PMID: 35976641, DOI: 10.1001/jamadermatol.2022.3109.Commentaries, Editorials and Letters
2020
Measurement properties of instruments assessing psoriatic arthritis symptoms for psoriasis clinical trials: a systematic literature review
Perez-Chada LM, Balak D, Cohen JM, Ogdie A, Merola JF, Gottlieb AB. Measurement properties of instruments assessing psoriatic arthritis symptoms for psoriasis clinical trials: a systematic literature review. Expert Review Of Clinical Immunology 2020, 16: 267-283. PMID: 32037912, DOI: 10.1080/1744666x.2020.1724090.Peer-Reviewed Original ResearchConceptsPatient global assessmentInternational Dermatology Outcome MeasuresPsoriatic arthritis symptomsPsoriasis clinical trialsArthritis symptomsQuality evidenceClinical trialsMeasurement propertiesContent validityRisk of biasMeasurement of painLevel of evidencePsA ImpactPsA symptomsGlobal assessment instrumentsFurther validation studiesDisease 9Physical functionOutcome measuresEligible articlesCOSMIN checklistGlobal assessmentSymptomsSymptom measuresPsAID12
2019
Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials
Perez-Chada LM, Gottlieb AB, Cohen J, Mease P, Duffin KC, Garg A, Latella J, Armstrong AW, Ogdie A, Merola JF. Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials. Journal Of The American Academy Of Dermatology 2019, 82: 54-61. PMID: 31163240, DOI: 10.1016/j.jaad.2019.05.075.Peer-Reviewed Original ResearchConceptsPsA symptomsPsoriasis trialsOutcome measuresConsensus meetingPatient Index Data 3International Dermatology Outcome MeasuresPatient association representativesPsoriatic Arthritis ImpactPsoriatic arthritis symptomsPsoriasis clinical trialsAppropriate outcome measuresConsensus-building studyDelphi surveyPSA screeningArthritis ImpactArthritis symptomsPsoriatic arthritisDisease 9Psoriasis studiesClinical trialsTrial participantsSymptomsQuality appraisalAcceptable alternativeData 3
2018
Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiative
Perez-Chada LM, Cohen JM, Gottlieb AB, Duffin KC, Garg A, Latella J, Armstrong AW, Ogdie A, Merola JF. Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiative. Archives Of Dermatological Research 2018, 310: 701-710. PMID: 30167814, DOI: 10.1007/s00403-018-1855-3.Peer-Reviewed Original ResearchConceptsInternational Dermatology Outcome MeasuresPsA symptomsPsoriasis clinical trialsPsoriatic arthritisClinical trialsHealth Measurement INstruments (COSMIN) guidelinesPatient Index DataPsoriatic Arthritis ImpactInternational Dermatology Outcome Measures (IDEOM) initiativeRole of PSAMost study participantsPatient GlobalArthritis ImpactPsoriasis therapyOutcome measuresTrial participantsRAPID3SymptomsStudy participantsArthritisRCTsResponsive measurePSAMost participantsTrials514 A pre-Delphi consensus exercise to define screening for psoriatic arthritis and measurement of psoriatic arthritis symptoms in psoriasis clinical trials
Perez-Chada L, Cohen J, Gottlieb A, Duffin K, Garg A, Latella J, Armstrong A, Ogdie A, Merola J. 514 A pre-Delphi consensus exercise to define screening for psoriatic arthritis and measurement of psoriatic arthritis symptoms in psoriasis clinical trials. Journal Of Investigative Dermatology 2018, 138: s88. DOI: 10.1016/j.jid.2018.03.522.Peer-Reviewed Original Research